## Abstract Two groups of 3 rabbits each were immunized with either recombinant vaccinia virus, WR‐SFB5env, carrying the human T‐cell lymphotropic virus type I (HTLV‐1) __env__ gene at the site of the hemagglutinin gene of the WR strain, or control vaccinia virus, HA‐WR, lacking the functional hema
Production, purification, and serologic application of a recombinant peptide from the carboxyl terminus of the χ gene protein of human T-cell lymphotropic virus type I
✍ Scribed by Samuel, Kenneth P.; Virgilio, Laura; Dubois, Garrett C.; Showalter, Stephen; Wong-Staal, Flossie; Papas, Takis S.
- Book ID
- 123182113
- Publisher
- Elsevier Science
- Year
- 1986
- Weight
- 999 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0735-0651
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Two types of recombinant vaccinia viruses (VVs) expressing the env gene of the human T-cell leukemia virus type I (HTLV-I) were reported previously. One recombinant VV, WR-proenv1, synthesized the authentic env protein. In the other recombinant VV, WR-env17, the env gene was inserted within the sign
A 42-kDa recombinant protein, PX141, consisting of the trans-activator protein encoded by human T-cell leukemia virus (HTLV-I) (tax, antigen) and the amino-terminal fusion peptide of I 2 amino acid residues of the a-peptide encoded by the plasmid pUC I 9 was produced. In order to investigate the imm